Retatrutide (30mg)

Retatrutide is a triple hormone receptor agonist that targets the GLP-1, GIP, and glucagon receptors, making it a significant focus of metabolic research. Its unique multi-receptor activity has generated interest for its potential effects on energy balance, glucose regulation, appetite signaling, and body composition.

Commonly utilized in laboratory research, Retatrutide is of interest in studies involving metabolic function, weight regulation, insulin sensitivity, and energy expenditure. 

For informational purposes only. Consult with a qualified healthcare professional before use.